Home / Latest Reports / Facial Injectable Market

Facial Injectable Market By Type, Application, Key Players and Regions - Global Industry Analysis & Forecast to 2027

Published On : August 2022 Pages : 145 Category: Pharma & Healthcare Report Code : HC0817791

Request Sample Inquiry Before Buying Request for Customization Check Discount

The global Facial Injectable Market is valued at USD XX billion in 2021 and is projected to reach USD XX billion by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.

The report exhibit detail coverage of Facial Injectable industry and market trends. The report also analyses present and past market values to forecast potential market through the forecast period between 2022-2027. This research study of Facial Injectable Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

In addition, the report provides insight into main drivers, challenges, opportunities and risk of the market and strategies of suppliers. Key players are profiled as well. Overall, this report covers the historical situation, present status and the future prospects of the global Facial Injectable Market for 2017-2027.

Crystal Market Research envisions that the span of the Facial Injectable Market will develop amid the estimated time frame as the Compound Annual Growth Rate boosts significantly. The objective of the market research report is the current status of the market and in accordance classifies it into a few portions. The report takes into consideration the prime market players in every area from over the globe.

Our research study analyses the size of the global market of Facial Injectable in primary regions such as North America, South America, Middle East & Africa, Asia Pacific and Europe. It also classifies the Facial Injectable Market by key manufacturers, region, type and application. Furthermore, this study examines in the status of the market, market share, future trends, growth rate, competitive landscape, opportunities, market driving factors and restraints, and challenges.

To stay updated with the latest technology and functions of the industry, Crystal Market Research regularly performs interviews with several industry experts and visits for its expert research analysts. The data sources include but not limited to reports of company’s, international organizations and governments, MMI market surveys, and related industry news.

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the Facial Injectable Market on the basis of type, application, and region:

Competitive Analysis                    

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Ipsen
  • Merz Pharma
  • Suneva Medical, Inc.
  • Medytox Inc.
  • Sinclair Pharma
  • Bloomage BioTechnology Corporation Limited
  • Anika Therapeutics Inc.
  • Prollenium Medical Technologies
  • Galderma
  • Allergan, Inc.
  • Nestle Skin Health
  • Zimmer Biomet
  • Abbvie Inc
  • SciVision Biotech Inc
  • Bioaxis Pharmaceuticals
  • Bioplus Co. Ltd
  • Revance Therapeutics Inc
  • Croma-Pharma GmbH

By Type

  • Collagen
  • Hyaluronic Acid
  • Botulinum Toxin Type A
  • Calcium Hydroxylapatite
  • Polymer Fillers

By Application

  • Therapeutics
  • Aesthetics

By Region

  • North America (US, Canada)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Mexico, Columbia, Rest of South America)
  • Middle East and Africa (Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA)

Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2022 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Table of Contents

1.     Introduction

1.1.  Report Description

1.2.  Research Methodology

1.2.1.     Data Mining

1.2.2.     Market Modeling and Forecasting

1.2.3.     Data Validation

1.2.4.     Industry Analysis

2.     Market Dashboard

3.     Market Overview

3.1.  Introduction

3.1.1.     Market Definition

3.1.2.     Market Segmentation

3.2.  Market Dynamics

3.2.1.     Drivers

3.2.2.     Restraints

3.2.3.     Opportunities

3.2.4.     Challenges

4.     Facial Injectable Market, By Type

4.1.  Introduction

4.2.  Facial Injectable Market Size and Growth Rate By Type (2017-2022)

4.3.  Collagen

4.3.1.     Global Collagen Market Size and Growth Rate (2017-2022)

4.4.  Hyaluronic Acid

4.4.1.     Global Hyaluronic Acid Market Size and Growth Rate (2017-2022)

4.5.  Botulinum Toxin Type A

4.5.1.     Global Botulinum Toxin Type A Market Size and Growth Rate (2017-2022)

4.6.  Calcium Hydroxylapatite

4.6.1.     Global Calcium Hydroxylapatite Market Size and Growth Rate (2017-2022)

4.7.  Polymer Fillers

4.7.1.     Global Polymer Fillers Market Size and Growth Rate (2017-2022)

5.     Facial Injectable Market, By Application

5.1.  Introduction

5.2.  Facial Injectable Market Size and Growth Rate By Application (2017-2022)

5.3.  Therapeutics

5.3.1.     Global Therapeutics Market Size and Growth Rate (2017-2022)

5.4.  Aesthetics

5.4.1.     Global Aesthetics Market Size and Growth Rate (2017-2022)

6.     Facial Injectable Market, By Region

6.1.  Introduction

6.2.  Facial Injectable Market Size and Growth Rate By Regions

6.2  North America

6.2.1.     North America Facial Injectable Market Size and Growth Rate (2017-2022))

6.2.2.     North America Facial Injectable Market By Type (2017-2022)

6.2.3.     North America Facial Injectable Market By Application (2017-2022)

6.2.4.     North America Facial Injectable Market By Country (2017-2022)

6.2.5.     United States

6.2.5.1.United States Facial Injectable Market Size and Growth Rate (2017-2022)

6.2.5.2.United States Facial Injectable Market By Type (2017-2022)

6.2.5.3.United States Facial Injectable Market By Application (2017-2022)

6.2.6.     Canada

6.2.6.1.Canada Facial Injectable Market Size and Growth Rate (2017-2022)

6.2.6.2.Canada Facial Injectable Market By Type (2017-2022)

6.2.6.3.Canada Facial Injectable Market By Application (2017-2022)

6.3  Europe

6.3.1.     Europe Facial Injectable Market Size and Growth Rate (2017-2022))

6.3.2.     Europe Facial Injectable Market By Type (2017-2022)

6.3.3.     Europe Facial Injectable Market By Application (2017-2022)

6.3.4.     Europe Facial Injectable Market By Country (2017-2022)

6.3.5.     Germany

6.3.5.1.Germany Facial Injectable Market Size and Growth Rate (2017-2022)

6.3.5.2.Germany Facial Injectable Market By Type (2017-2022)

6.3.5.3.Germany Facial Injectable Market By Application (2017-2022)

6.3.6.     France

6.3.6.1.France Facial Injectable Market Size and Growth Rate (2017-2022)

6.3.6.2.France Facial Injectable Market By Type (2017-2022)

6.3.6.3.France Facial Injectable Market By Application (2017-2022)

6.3.7.     UK

6.3.7.1.UK Facial Injectable Market Size and Growth Rate (2017-2022)

6.3.7.2.UK Facial Injectable Market By Type (2017-2022)

6.3.7.3.UK Facial Injectable Market By Application (2017-2022)

6.3.8.     Russia

6.3.8.1.Russia Facial Injectable Market Size and Growth Rate (2017-2022)

6.3.8.2.Russia Facial Injectable Market By Type (2017-2022)

6.3.8.3.Russia Facial Injectable Market By Application (2017-2022)

6.3.9.     Italy

6.3.9.1.Italy Facial Injectable Market Size and Growth Rate (2017-2022)

6.3.9.2.Italy Facial Injectable Market By Type (2017-2022)

6.3.9.3.Italy Facial Injectable Market By Application (2017-2022)

6.3.10.     Rest of Europe

6.3.10.1.Rest of Europe Facial Injectable Market Size and Growth Rate (2017-2022)

6.3.10.2.Rest of Europe Facial Injectable Market By Type (2017-2022)

6.3.10.3.Rest of Europe Facial Injectable Market By Application (2017-2022)

6.4  Asia-Pacific

6.4.1.     Asia-Pacific Facial Injectable Market Size and Growth Rate (2017-2022))

6.4.2.     Asia-Pacific Facial Injectable Market By Type (2017-2022)

6.4.3.     Asia-Pacific Facial Injectable Market By Application (2017-2022)

6.4.4.     Asia-Pacific Facial Injectable Market By Country (2017-2022)

6.4.5.     China

6.4.5.1.China Facial Injectable Market Size and Growth Rate (2017-2022)

6.4.5.2.China Facial Injectable Market By Type (2017-2022)

6.4.5.3.China Facial Injectable Market By Application (2017-2022)

6.4.6.     Japan

6.4.6.1.Japan Facial Injectable Market Size and Growth Rate (2017-2022)

6.4.6.2.Japan Facial Injectable Market By Type (2017-2022)

6.4.6.3.Japan Facial Injectable Market By Application (2017-2022)

6.4.7.     Korea

6.4.7.1.Korea Facial Injectable Market Size and Growth Rate (2017-2022)

6.4.7.2.Korea Facial Injectable Market By Type (2017-2022)

6.4.7.3.Korea Facial Injectable Market By Application (2017-2022)

6.4.8.     India

6.4.8.1.India Facial Injectable Market Size and Growth Rate (2017-2022)

6.4.8.2.India Facial Injectable Market By Type (2017-2022)

6.4.8.3.India Facial Injectable Market By Application (2017-2022)

6.4.9.     Southeast Asia

6.4.9.1.Southeast Asia Facial Injectable Market Size and Growth Rate (2017-2022)

6.4.9.2.Southeast Asia Facial Injectable Market By Type (2017-2022)

6.4.9.3.Southeast Asia Facial Injectable Market By Application (2017-2022)

6.4.10.     Rest of Asia-Pacific

6.4.10.1.Rest of Asia-Pacific Facial Injectable Market Size and Growth Rate (2017-2022)

6.4.10.2.Rest of Asia-Pacific Facial Injectable Market By Type (2017-2022)

6.4.10.3.Rest of Asia-Pacific Facial Injectable Market By Application (2017-2022)

6.5  South America

6.5.1.     South America Facial Injectable Market Size and Growth Rate (2017-2022))

6.5.2.     South America Facial Injectable Market By Type (2017-2022)

6.5.3.     South America Facial Injectable Market By Application (2017-2022)

6.5.4.     South America Facial Injectable Market By Country (2017-2022)

6.5.5.     Brazil

6.5.5.1.Brazil Facial Injectable Market Size and Growth Rate (2017-2022)

6.5.5.2.Brazil Facial Injectable Market By Type (2017-2022)

6.5.5.3.Brazil Facial Injectable Market By Application (2017-2022)

6.5.6.     Mexico

6.5.6.1.Mexico Facial Injectable Market Size and Growth Rate (2017-2022)

6.5.6.2.Mexico Facial Injectable Market By Type (2017-2022)

6.5.6.3.Mexico Facial Injectable Market By Application (2017-2022)

6.5.7.     Columbia

6.5.7.1.Columbia Facial Injectable Market Size and Growth Rate (2017-2022)

6.5.7.2.Columbia Facial Injectable Market By Type (2017-2022)

6.5.7.3.Columbia Facial Injectable Market By Application (2017-2022)

6.5.8.     Rest of South America

6.5.8.1.Rest of South America Facial Injectable Market Size and Growth Rate (2017-2022)

6.5.8.2.Rest of South America Facial Injectable Market By Type (2017-2022)

6.5.8.3.Rest of South America Facial Injectable Market By Application (2017-2022)

6.6  Middle East and Africa

6.6.1.     Middle East and Africa Facial Injectable Market Size and Growth Rate (2017-2022))

6.6.2.     Middle East and Africa Facial Injectable Market By Type (2017-2022)

6.6.3.     Middle East and Africa Facial Injectable Market By Application (2017-2022)

6.6.4.     Middle East and Africa Facial Injectable Market By Country (2017-2022)

6.6.5.     Saudi Arabia

6.6.5.1.Saudi Arabia Facial Injectable Market Size and Growth Rate (2017-2022)

6.6.5.2.Saudi Arabia Facial Injectable Market By Type (2017-2022)

6.6.5.3.Saudi Arabia Facial Injectable Market By Application (2017-2022)

6.6.6.     United Arab Emirates

6.6.6.1.United Arab Emirates Facial Injectable Market Size and Growth Rate (2017-2022)

6.6.6.2.United Arab Emirates Facial Injectable Market By Type (2017-2022)

6.6.6.3.United Arab Emirates Facial Injectable Market By Application (2017-2022)

6.6.7.     South Africa

6.6.7.1.South Africa Facial Injectable Market Size and Growth Rate (2017-2022)

6.6.7.2.South Africa Facial Injectable Market By Type (2017-2022)

6.6.7.3.South Africa Facial Injectable Market By Application (2017-2022)

6.6.8.     Rest of Middle East and Africa

6.6.8.1.Rest of Middle East and Africa Facial Injectable Market Size and Growth Rate (2017-2022)

6.6.8.2.Rest of Middle East and Africa Facial Injectable Market By Type (2017-2022)

6.6.8.3.Rest of Middle East and Africa Facial Injectable Market By Application (2017-2022)

7.     Company Profiles

7.1.  Ipsen

7.1.1.     Business Overview

7.1.2.     Service Portfolio

7.1.3.     Strategic Developments

7.1.4.     Financial Overview

7.2.  Merz Pharma

7.2.1.     Business Overview

7.2.2.     Service Portfolio

7.2.3.     Strategic Developments

7.2.4.     Financial Overview

7.3.  Suneva Medical, Inc.

7.3.1.     Business Overview

7.3.2.     Service Portfolio

7.3.3.     Strategic Developments

7.3.4.     Financial Overview

7.4.  Medytox Inc.

7.4.1.     Business Overview

7.4.2.     Service Portfolio

7.4.3.     Strategic Developments

7.4.4.     Financial Overview

7.5.  Sinclair Pharma

7.5.1.     Business Overview

7.5.2.     Service Portfolio

7.5.3.     Strategic Developments

7.5.4.     Financial Overview

7.6.  Bloomage BioTechnology Corporation Limited

7.6.1.     Business Overview

7.6.2.     Service Portfolio

7.6.3.     Strategic Developments

7.6.4.     Financial Overview

7.7.  Anika Therapeutics Inc.

7.7.1.     Business Overview

7.7.2.     Service Portfolio

7.7.3.     Strategic Developments

7.7.4.     Financial Overview

7.8.  Prollenium Medical Technologies

7.8.1.     Business Overview

7.8.2.     Service Portfolio

7.8.3.     Strategic Developments

7.8.4.     Financial Overview

7.9.  Galderma

7.9.1.     Business Overview

7.9.2.     Service Portfolio

7.9.3.     Strategic Developments

7.9.4.     Financial Overview

7.10.  Allergan, Inc.

7.10.1.     Business Overview

7.10.2.     Service Portfolio

7.10.3.     Strategic Developments

7.10.4.     Financial Overview

7.11.  Nestle Skin Health

7.11.1.     Business Overview

7.11.2.     Service Portfolio

7.11.3.     Strategic Developments

7.11.4.     Financial Overview

7.12.  Zimmer Biomet

7.12.1.     Business Overview

7.12.2.     Service Portfolio

7.12.3.     Strategic Developments

7.12.4.     Financial Overview

7.13.  Abbvie Inc

7.13.1.     Business Overview

7.13.2.     Service Portfolio

7.13.3.     Strategic Developments

7.13.4.     Financial Overview

7.14.  SciVision Biotech Inc

7.14.1.     Business Overview

7.14.2.     Service Portfolio

7.14.3.     Strategic Developments

7.14.4.     Financial Overview

7.15.  Bioaxis Pharmaceuticals

7.15.1.     Business Overview

7.15.2.     Service Portfolio

7.15.3.     Strategic Developments

7.15.4.     Financial Overview

7.16.  Bioplus Co. Ltd

7.16.1.     Business Overview

7.16.2.     Service Portfolio

7.16.3.     Strategic Developments

7.16.4.     Financial Overview

7.17.  Revance Therapeutics Inc

7.17.1.     Business Overview

7.17.2.     Service Portfolio

7.17.3.     Strategic Developments

7.17.4.     Financial Overview

7.18.  Croma-Pharma GmbH

7.18.1.     Business Overview

7.18.2.     Service Portfolio

7.18.3.     Strategic Developments

7.18.4.     Financial Overview

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2027)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*